locally advanced prostate cancer generally refers patients clinical stages disease patients locally advanced cancer frequently included clinical trials examine treatment patients high risk relapse based presenting antigen high gleason score advanced clinical stage growing body evidence suggests men localized prostate cancer benefit radiation therapy delivered conformal radiation therapy radiation therapy proton beam therapy importantly neoadjuvant adjuvant therapy significantly improved outcomes men locally advanced prostate cancer questions remain regarding optimal timing duration adjuvant hormonal therapy combination androgen deprivation started radiation therapy continued NUMBER years represents north american standard care patient population references NUMBER t3 NUMBER prostate specific high dose dimensional intensity modulated androgen deprivation high risk long term